{"count": 7, "results": [{"_id": "31955966", "pmid": 31955966, "title": "Influence of Statins on Circulating Inflammatory Cytokines in Patients With Abnormal Glucose Homeostasis: A Meta-analysis of Data From Randomized Controlled Trials.", "journal": "Clin Ther", "authors": ["Milajerdi A", "Sadeghi A", "Mousavi SM", "Larijani B", "Esmaillzadeh A"], "date": "2020-02-01T00:00:00Z", "doi": "10.1016/j.clinthera.2019.12.009", "meta_date_publication": "2020 Feb", "meta_volume": "42", "meta_issue": "2", "meta_pages": "e13-e31", "score": 50261.402, "text_hl": "IMPLICATIONS: The administration of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ or @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ in @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Glucose_Metabolism_Disorders</m> @DISEASE_MESH:D044882 @@@abnormal glucose@@@ hemostasis was associated with a reduced serum @GENE_CRP @GENE_1401 @@@CRP@@@ concentration. ", "citations": {"NLM": "Milajerdi A, Sadeghi A, Mousavi SM, Larijani B, Esmaillzadeh A. Influence of Statins on Circulating Inflammatory Cytokines in Patients With Abnormal Glucose Homeostasis: A Meta-analysis of Data From Randomized Controlled Trials. Clin Ther. 2020 Feb;42(2):e13-e31. PMID: 31955966", "BibTeX": "@article{31955966, title={Influence of Statins on Circulating Inflammatory Cytokines in Patients With Abnormal Glucose Homeostasis: A Meta-analysis of Data From Randomized Controlled Trials.}, author={Milajerdi A and Sadeghi A and Mousavi SM and Larijani B and Esmaillzadeh A}, journal={Clin Ther}, volume={42}, number={2}, pages={e13-e31}}"}}, {"_id": "34995578", "pmid": 34995578, "title": "Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism.", "journal": "Metabolism", "authors": ["Wang L", "Zhu L", "Zheng Z", "Meng L", "Liu H", "Wang K", "Chen J", "Li P", "Yang H"], "date": "2022-03-01T00:00:00Z", "doi": "10.1016/j.metabol.2021.155120", "meta_date_publication": "2022 Mar", "meta_volume": "128", "meta_issue": "", "meta_pages": "155120", "score": 50253.887, "text_hl": "@CHEMICAL_geranylgeraniol @CHEMICAL_MESH:C017338 @@@Geranylgeraniol@@@ (GGOH), a precursor of @CHEMICAL_geranylgeranyl_pyrophosphate @CHEMICAL_MESH:C002963 @@@GGPP@@@, is able to ameliorate @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-induced systemic @<m>DISEASE_Glucose_Metabolism_Disorders</m> @DISEASE_MESH:D044882 @@@glucose metabolism disorders@@@ in vivo. ", "citations": {"NLM": "Wang L, Zhu L, Zheng Z, Meng L, Liu H, Wang K, Chen J, Li P, Yang H. Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism. Metabolism. 2022 Mar;128():155120. PMID: 34995578", "BibTeX": "@article{34995578, title={Mevalonate pathway orchestrates insulin signaling via RAB14 geranylgeranylation-mediated phosphorylation of AKT to regulate hepatic glucose metabolism.}, author={Wang L and Zhu L and Zheng Z and Meng L and Liu H and Wang K and Chen J and Li P and Yang H}, journal={Metabolism}, volume={128}, pages={155120}}"}}, {"_id": "32942550", "pmid": 32942550, "pmcid": "PMC7555587", "title": "Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1alpha Skeletal Muscle Expression", "journal": "Biomedicines", "authors": ["Panajatovic MV", "Singh F", "Krähenbühl S", "Bouitbir J"], "date": "2020-09-15T00:00:00Z", "doi": "10.3390/biomedicines8090351", "meta_date_publication": "2020 Sep 15", "meta_volume": "8", "meta_issue": "9", "meta_pages": "", "score": 50250.688, "text_hl": "...3.2. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ @<m>DISEASE_Glucose_Metabolism_Disorders</m> @DISEASE_MESH:D044882 @@@Impaired Glucose Homeostasis@@@ in WT and OE @SPECIES_10090 @@@Mice@@@ Whereas KO @SPECIES_10090 @@@Mice@@@ Showed Already Higher Blood @CHEMICAL_Glucose @CHEMICAL_MESH:D005947 @@@Glucose@@@ Concentrations during the iGTT Without @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ Treatment", "citations": {"NLM": "Panajatovic MV, Singh F, Krähenbühl S, Bouitbir J. Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1alpha Skeletal Muscle Expression Biomedicines. 2020 Sep 15;8(9):. PMID: 32942550", "BibTeX": "@article{32942550, title={Simvastatin Impairs Glucose Homeostasis in Mice Depending on PGC-1alpha Skeletal Muscle Expression}, author={Panajatovic MV and Singh F and Krähenbühl S and Bouitbir J}, journal={Biomedicines}, volume={8}, number={9}}"}}, {"_id": "34517987", "pmid": 34517987, "title": "Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study.", "journal": "Med Clin (Barc)", "authors": ["Trias F", "Pintó X", "Corbella E", "Suárez-Tembra M", "Ruíz-García A", "Díaz-Díaz JL", "Sánchez-Ruíz-Granado E", "Sarasa I", "Martínez-Porqueras R", "Rodríguez-Sánchez MA", "Corbella X", "PRELIPID Study Group"], "date": "2022-06-10T00:00:00Z", "doi": "10.1016/j.medcli.2021.06.018", "meta_date_publication": "2022 Jun 10", "meta_volume": "158", "meta_issue": "11", "meta_pages": "531-539", "score": 50244.934, "text_hl": "CONCLUSIONS: This study suggests that there are differences in the diabetogenic effect of statins. @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ and high doses of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ may be associated with greater @<m>DISEASE_Glucose_Metabolism_Disorders</m> @DISEASE_MESH:D044882 @@@impairment in glucose metabolism@@@ than @CHEMICAL_pitavastatin @CHEMICAL_MESH:C108475 @@@pitavastatin@@@ and other statins with less @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@lipid@@@-lowering potency such as @CHEMICAL_Pravastatin @CHEMICAL_MESH:D017035 @@@pravastatin@@@.", "citations": {"NLM": "Trias F, Pintó X, Corbella E, Suárez-Tembra M, Ruíz-García A, Díaz-Díaz JL, Sánchez-Ruíz-Granado E, Sarasa I, Martínez-Porqueras R, Rodríguez-Sánchez MA, Corbella X, PRELIPID Study Group. Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study. Med Clin (Barc). 2022 Jun 10;158(11):531-539. PMID: 34517987", "BibTeX": "@article{34517987, title={Differences in the diabetogenic effect of statins in patients with prediabetes. The PRELIPID study.}, author={Trias F and Pintó X and Corbella E and Suárez-Tembra M and Ruíz-García A and Díaz-Díaz JL and Sánchez-Ruíz-Granado E and Sarasa I and Martínez-Porqueras R and Rodríguez-Sánchez MA and Corbella X and PRELIPID Study Group}, journal={Med Clin (Barc)}, volume={158}, number={11}, pages={531-539}}"}}, {"_id": "22935083", "pmid": 22935083, "title": "The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Krysiak R", "Gdula-Dymek A", "Okopien B"], "date": "2013-03-01T00:00:00Z", "doi": "10.1111/bcpt.12003", "meta_date_publication": "2013 Mar", "meta_volume": "112", "meta_issue": "3", "meta_pages": "198-202", "score": 50059.824, "text_hl": "The effect of @CHEMICAL_Fenofibrate @CHEMICAL_MESH:D011345 @@@fenofibrate@@@ on lymphocyte release of proinflammatory cytokines and systemic @DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammation@@@ in @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@-treated @SPECIES_9606 @@@patients@@@ with @DISEASE_Atherosclerosis @DISEASE_MESH:D050197 @@@atherosclerosis@@@ and early @<m>DISEASE_Glucose_Metabolism_Disorders</m> @DISEASE_MESH:D044882 @@@glucose metabolism disturbances@@@.", "citations": {"NLM": "Krysiak R, Gdula-Dymek A, Okopien B. The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances. Basic Clin Pharmacol Toxicol. 2013 Mar;112(3):198-202. PMID: 22935083", "BibTeX": "@article{22935083, title={The effect of fenofibrate on lymphocyte release of proinflammatory cytokines and systemic inflammation in simvastatin-treated patients with atherosclerosis and early glucose metabolism disturbances.}, author={Krysiak R and Gdula-Dymek A and Okopien B}, journal={Basic Clin Pharmacol Toxicol}, volume={112}, number={3}, pages={198-202}}"}}, {"_id": "20955358", "pmid": 20955358, "title": "Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose.", "journal": "Basic Clin Pharmacol Toxicol", "authors": ["Krysiak R", "Gdula-Dymek A", "Scieszka J", "Okopień B"], "date": "2011-02-01T00:00:00Z", "doi": "10.1111/j.1742-7843.2010.00633.x", "meta_date_publication": "2011 Feb", "meta_volume": "108", "meta_issue": "2", "meta_pages": "131-7", "score": 50052.684, "text_hl": "They also show that @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ is an effective anti-@DISEASE_Inflammation @DISEASE_MESH:D007249 @@@inflammatory@@@ drug in @SPECIES_9606 @@@patients@@@ with isolated early @<m>DISEASE_Glucose_Metabolism_Disorders</m> @DISEASE_MESH:D044882 @@@glucose metabolism abnormalities@@@.", "citations": {"NLM": "Krysiak R, Gdula-Dymek A, Scieszka J, Okopień B. Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose. Basic Clin Pharmacol Toxicol. 2011 Feb;108(2):131-7. PMID: 20955358", "BibTeX": "@article{20955358, title={Anti-inflammatory and monocyte-suppressing effects of simvastatin in patients with impaired fasting glucose.}, author={Krysiak R and Gdula-Dymek A and Scieszka J and Okopień B}, journal={Basic Clin Pharmacol Toxicol}, volume={108}, number={2}, pages={131-7}}"}}, {"_id": "20529243", "pmid": 20529243, "pmcid": "PMC2902423", "title": "Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects", "journal": "Diabetol Metab Syndr", "authors": ["Kater AL", "Batista MC", "Ferreira SR"], "date": "2010-06-07T00:00:00Z", "doi": "10.1186/1758-5996-2-34", "meta_date_publication": "2010 Jun 7", "meta_volume": "2", "meta_issue": "", "meta_pages": "34", "score": 50048.508, "text_hl": "Expected synergistic lowering effects of a @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Ezetimibe @CHEMICAL_MESH:D000069438 @@@ezetimibe@@@ combination on LDL-cholesterol, @GENE_APOB @GENE_338 @@@apolipoprotein B@@@ and @CHEMICAL_Triglycerides @CHEMICAL_MESH:D014280 @@@triglycerides@@@ levels were confirmed in subjects with early @<m>DISEASE_Glucose_Metabolism_Disorders</m> @DISEASE_MESH:D044882 @@@disturbances of glucose metabolism@@@. ", "citations": {"NLM": "Kater AL, Batista MC, Ferreira SR. Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects Diabetol Metab Syndr. 2010 Jun 7;2():34. PMID: 20529243", "BibTeX": "@article{20529243, title={Synergistic effect of simvastatin and ezetimibe on lipid and pro-inflammatory profiles in pre-diabetic subjects}, author={Kater AL and Batista MC and Ferreira SR}, journal={Diabetol Metab Syndr}, volume={2}, pages={34}}"}}]}